127 related articles for article (PubMed ID: 8063047)
1. Amylin tonally regulates arginine-stimulated insulin secretion in rats.
Bennet WM; Beis CS; Ghatei MA; Byfield PG; Bloom SR
Diabetologia; 1994 Apr; 37(4):436-8. PubMed ID: 8063047
[TBL] [Abstract][Full Text] [Related]
2. Effects of amylin on the release of insulin and glucagon from the perfused rat pancreas.
Inoue K; Hiramatsu S; Hisatomi A; Umeda F; Nawata H
Horm Metab Res; 1993 Mar; 25(3):135-7. PubMed ID: 8477949
[TBL] [Abstract][Full Text] [Related]
3. The effect of islet amyloid polypeptide (amylin) and calcitonin gene-related peptide on glucose removal in the anaesthetized rat and on insulin secretion from rat pancreatic islets in vitro.
Tedstone AE; Nezzer T; Hughes SJ; Clark A; Matthews DR
Biosci Rep; 1990 Aug; 10(4):339-45. PubMed ID: 2249001
[TBL] [Abstract][Full Text] [Related]
4. Dose-response for glucagonostatic effect of amylin in rats.
Gedulin BR; Rink TJ; Young AA
Metabolism; 1997 Jan; 46(1):67-70. PubMed ID: 9005972
[TBL] [Abstract][Full Text] [Related]
5. Selective amylin inhibition of the glucagon response to arginine is extrinsic to the pancreas.
Silvestre RA; Rodríguez-Gallardo J; Jodka C; Parkes DG; Pittner RA; Young AA; Marco J
Am J Physiol Endocrinol Metab; 2001 Mar; 280(3):E443-9. PubMed ID: 11171599
[TBL] [Abstract][Full Text] [Related]
6. Islet amyloid polypeptide (IAPP;amylin) influences the endocrine but not the exocrine rat pancreas.
Fehmann HC; Weber V; Göke R; Göke B; Eissele R; Arnold R
Biochem Biophys Res Commun; 1990 Mar; 167(3):1102-8. PubMed ID: 1690993
[TBL] [Abstract][Full Text] [Related]
7. 8-37hCGRP, an amylin receptor antagonist, enhances the insulin response and perturbs the glucose response to infused arginine in anesthetized rats.
Young AA; Carlo P; Rink TJ; Wang MW
Mol Cell Endocrinol; 1992 Mar; 84(1-2):R1-5. PubMed ID: 1322328
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of rat amylin on the insulin responses to glucose and arginine in the perfused rat pancreas.
Silvestre RA; Peiró E; Dégano P; Miralles P; Marco J
Regul Pept; 1990 Oct; 31(1):23-31. PubMed ID: 2270316
[TBL] [Abstract][Full Text] [Related]
9. Impaired phasic insulin and amylin secretion in diabetic rats.
Leahy JL; Fineman MS
Am J Physiol; 1998 Sep; 275(3):E457-62. PubMed ID: 9725812
[TBL] [Abstract][Full Text] [Related]
10. Amylin inhibits glucose-induced insulin secretion in a dose-dependent manner. Study in the perfused rat pancreas.
Dégano P; Silvestre RA; Salas M; Peiró E; Marco J
Regul Pept; 1993 Jan; 43(1-2):91-6. PubMed ID: 8426912
[TBL] [Abstract][Full Text] [Related]
11. Relative hypersecretion of amylin to insulin from rat pancreas after neonatal STZ treatment.
Inoue K; Hisatomi A; Umeda F; Nawata H
Diabetes; 1992 Jun; 41(6):723-7. PubMed ID: 1534057
[TBL] [Abstract][Full Text] [Related]
12. Islet amyloid polypeptide tonally inhibits beta-, alpha-, and delta-cell secretion in isolated rat pancreatic islets.
Wang F; Adrian TE; Westermark GT; Ding X; Gasslander T; Permert J
Am J Physiol; 1999 Jan; 276(1):E19-24. PubMed ID: 9886946
[TBL] [Abstract][Full Text] [Related]
13. Release of amylin from perfused rat pancreas in response to glucose, arginine, beta-hydroxybutyrate, and gliclazide.
Inoue K; Hisatomi A; Umeda F; Nawata H
Diabetes; 1991 Aug; 40(8):1005-9. PubMed ID: 1860552
[TBL] [Abstract][Full Text] [Related]
14. Effect of (8-32) salmon calcitonin, an amylin antagonist, on insulin, glucagon and somatostatin release: study in the perfused pancreas of the rat.
Silvestre RA; Salas M; Rodríguez-Gallardo J; García-Hermida O; Fontela T; Marco J
Br J Pharmacol; 1996 Jan; 117(2):347-50. PubMed ID: 8789389
[TBL] [Abstract][Full Text] [Related]
15. The effects of amylin on insulin secretion from Rin m5F cells and glycogen synthesis and lipogenesis in rat primary cultured hepatocytes.
Suzuki S; Murakami M; Abe S; Satoh Y; Shintani S; Ishizuka J; Suzuki K; Thompson JC; Toyota T
Diabetes Res Clin Pract; 1992 Jan; 15(1):77-84. PubMed ID: 1311671
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of insulin secretion, but normal peripheral insulin sensitivity, in a patient with a malignant endocrine pancreatic tumour producing high amounts of an islet amyloid polypeptide-like molecule.
Stridsberg M; Berne C; Sandler S; Wilander E; Oberg K
Diabetologia; 1993 Sep; 36(9):843-9. PubMed ID: 8405756
[TBL] [Abstract][Full Text] [Related]
17. Co-secretion of amylin and insulin from cultured islet beta-cells: modulation by nutrient secretagogues, islet hormones and hypoglycemic agents.
Moore CX; Cooper GJ
Biochem Biophys Res Commun; 1991 Aug; 179(1):1-9. PubMed ID: 1679326
[TBL] [Abstract][Full Text] [Related]
18. Lack of acute effect of amylin (islet associated polypeptide) on insulin sensitivity during hyperinsulinaemic euglycaemic clamp in humans.
Wilding JP; Khandan-Nia N; Bennet WM; Gilbey SG; Beacham J; Ghatei MA; Bloom SR
Diabetologia; 1994 Feb; 37(2):166-9. PubMed ID: 8163050
[TBL] [Abstract][Full Text] [Related]
19. Influence of islet amyloid polypeptide and the 8-37 fragment of islet amyloid polypeptide on insulin release from perifused rat islets.
Wang ZL; Bennet WM; Ghatei MA; Byfield PG; Smith DM; Bloom SR
Diabetes; 1993 Feb; 42(2):330-5. PubMed ID: 8425669
[TBL] [Abstract][Full Text] [Related]
20. Rat amylin-(8-37) enhances insulin action and alters lipid metabolism in normal and insulin-resistant rats.
Hettiarachchi M; Chalkley S; Furler SM; Choong YS; Heller M; Cooper GJ; Kraegen EW
Am J Physiol; 1997 Nov; 273(5):E859-67. PubMed ID: 9374670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
